These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19256257)

  • 41. [Rheodextran, vasodilating infusion and blood flow properties in patients with obliterative atherosclerosis of the lower extremities].
    Bulvas M; Linhart J
    Vnitr Lek; 1982 Sep; 28(9):902-7. PubMed ID: 6183828
    [No Abstract]   [Full Text] [Related]  

  • 42. [Behavior and meaning of beta-thromboglobulin in chronic obliterative arteriopathy of the lower extremities. Preliminary study].
    Binaghi F; Valle E; Manconi E; Pitzus F
    Cardiologia; 1982 Nov; 27(11):1043-9. PubMed ID: 6204655
    [No Abstract]   [Full Text] [Related]  

  • 43. Sleep duration as a risk factor for the development of type 2 diabetes or impaired glucose tolerance: analyses of the Quebec Family Study.
    Chaput JP; Després JP; Bouchard C; Astrup A; Tremblay A
    Sleep Med; 2009 Sep; 10(8):919-24. PubMed ID: 19332380
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Long-term results of coronary endovascular revascularisation with sirolimus-eluting stents in patients with ischemic heart disease comorbid with type-2 diabetes mellitus: data from 18-month prospective study].
    Tepliakov AT; Torim IuIu; Kuznetsova AV; Rybal'chenko EV; Krylov AL; Karpov RS
    Ter Arkh; 2009; 81(5):54-60. PubMed ID: 19537588
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hematocrit value in patients with sclerotic obstructive arteriopathy].
    Meciani L; Parmeggiani A; Prestipino F; Ricci G; Boeri S
    Minerva Cardioangiol; 1968 Feb; 16(2):81-91. PubMed ID: 5736319
    [No Abstract]   [Full Text] [Related]  

  • 46. Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients.
    Ezzidi I; Mtiraoui N; Chaieb M; Kacem M; Mahjoub T; Almawi WY
    Diabetes Metab; 2009 Jun; 35(3):214-9. PubMed ID: 19419896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carotid atherosclerosis mediated by visceral adiposity and adipocytokines in type 2 diabetic subjects.
    Konishi K; Nakano S; Seto H; Tsuda S; Koya D
    Diabetes Res Clin Pract; 2009 Aug; 85(2):171-8. PubMed ID: 19482369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Late results of endovascular coronary revascularization in patients with type 2 diabetes mellitus].
    Tepliakov AT; Kuznetsova AV; Torim IuIu; Stepacheva TA; Lukinov AV; Krylov AL
    Klin Med (Mosk); 2009; 87(2):50-5. PubMed ID: 19348303
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Unbalanced risk factors, could compromise the effectiveness of physical training in patients with intermittent claudication?
    Leone A; Laudani R; Definite G; Martini R; Andreozzi GM
    Minerva Cardioangiol; 2009 Apr; 57(2):165-74. PubMed ID: 19274027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Androgen pattern in patients with type 2 diabetes-associated erectile dysfunction: impact of metabolic control.
    El-Sakka AI; Sayed HM; Tayeb KA
    Urology; 2009 Sep; 74(3):552-9. PubMed ID: 19592073
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Peripheral venous blood concentration of lactates and pyruvates in patients with obliterative arteriosclerosis].
    Geraga W; Czechowicz Z; Jarkowska J; Piotrowicz-Kasprzakowa K; Chmielnicka-Pruszczyńska M
    Wiad Lek; 1978 Apr; 31(7):441-7. PubMed ID: 664673
    [No Abstract]   [Full Text] [Related]  

  • 52. [Hemodilution effect on the electrocardiogram and left-ventricular contraction dynamics in patients with obliterative arteriosclerosis].
    Dabrowski A; Daciewicz Z
    Pol Tyg Lek; 1982 Apr; 37(4-5):117-9. PubMed ID: 7111079
    [No Abstract]   [Full Text] [Related]  

  • 53. [Preoperative efferent therapy of patients with atherosclerosis obliterans of the lower limbs].
    Neĭmark MI; Elizar'ev AIu; Khorev NG
    Anesteziol Reanimatol; 1997; (2):58-61. PubMed ID: 9221693
    [No Abstract]   [Full Text] [Related]  

  • 54. Prevalence of upper and lower gastrointestinal symptoms in Greek patients with type 2 diabetes mellitus.
    Cholongitas E; Pipili C; Dasenaki M
    J Gastrointestin Liver Dis; 2008 Mar; 17(1):115-6. PubMed ID: 18392261
    [No Abstract]   [Full Text] [Related]  

  • 55. Hemorheologic changes in type 2 diabetic patients with microangiopathic skin lesions. A linear discriminant categorizing analysis.
    Carrera LI; Etchepare R; D'Arrigo M; Vaira SM; Valverde J; D'Ottavio AE; Foresto P
    J Diabetes Complications; 2008; 22(2):132-6. PubMed ID: 18280444
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel serotonin blocker, sarpogrelate, increases circulating adiponectin levels in diabetic patients with arteriosclerosis obliterans.
    Yamakawa J; Takahashi T; Itoh T; Kusaka K; Kawaura K; Wang XQ; Kanda T
    Diabetes Care; 2003 Aug; 26(8):2477-8. PubMed ID: 12882890
    [No Abstract]   [Full Text] [Related]  

  • 57. Packed cell volume in diabetes mellitus.
    Ruben LA; Pearson TC; Shenouda F; Sönksen PH
    Practitioner; 1986 Jul; 230(1417):649-51. PubMed ID: 3737554
    [No Abstract]   [Full Text] [Related]  

  • 58. Basophil leukocytes in arteriosclerosis obliterans.
    Gonciarz Z
    Pol Med J; 1968; 7(4):845-50. PubMed ID: 5727931
    [No Abstract]   [Full Text] [Related]  

  • 59. [The combination theory of the pathogenesis of atherosclerosis of the lower limbs and new perspectives in its therapy].
    Eristavi KD; Machabeli MS
    Khirurgiia (Mosk); 1965 Dec; 41(12):9-14. PubMed ID: 5878886
    [No Abstract]   [Full Text] [Related]  

  • 60. [The pathology of the foot in the atherosclerotic damage of lower extremities vessels in patients with type 2 diabetes mellitus].
    Kulikova AN; Nesnova ES
    Klin Med (Mosk); 2008; 86(7):52-5. PubMed ID: 18756749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.